Skip to main content
Log in

Hypoxia-induced increase of endostatin in murine aorta and lung

  • Original Paper
  • Published:
Histochemistry and Cell Biology Aims and scope Submit manuscript

Abstract

In the lung, hypoxia induces pulmonary hypertension caused by vasoconstriction and vascular remodeling. Additionally, hypoxia is an inducer of angiogenesis, which is assumed to counteract pulmonary hypertension. We asked whether the anti-angiogenic factor endostatin—a cleavage product of collagen XVIII—participates in the vascular alterations induced by hypoxia. By employing Western blotting of tissue extracts of murine brain, liver and heart an endostatin fragment of 22 kDa was detectable, whereas in lung and aorta additional bands of 24 and 26 kDa were found. The amount of these larger fragments was increased in tissues obtained from mice housed for 4 days or 3 weeks at hypobaric hypoxia. By immunohistochemistry endostatin was detected in association with elastic fibers and in close neighborhood to smooth muscle cells of intrapulmonary vessels and the aorta. In the lung, the activity of matrix metalloproteinases (MMP) known to generate endostatin by cleavage of collagen XVIII was increased (MMP-2) and decreased (proMMP-9), respectively, by hypoxia. Elevated amounts of endostatin within the aortic wall of mice exposed to hypobaric hypoxia may stabilize the vascular wall by inhibition of microvascular sprouting. The surprising finding of increased endostatin in the lung presumably contributes to the development of pulmonary hypertension by reduction of angiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Abbreviations

MMPs:

Matrix metalloproteinases

References

  • Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE (2004) Endostatin’s antiangiogenic signaling network. Mol Cell 13:649–663

    Google Scholar 

  • Burritt JB, Quinn MT, Jutila MA, Bond CW, Jesaitis AJ (1995) Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem 270:16974–16980

    Google Scholar 

  • Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW (2004) N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent. Oncol Rep 11:191–195

    Google Scholar 

  • Deininger MH, Fimmen B, Kremsner PG, Meyermann R, Schluesener HJ (2002a) Accumulation of endostatin/collagenXVIII in brains of patients who died with cerebral malaria. J Neuroimmunol 131:216–221

    Google Scholar 

  • Deininger MH, Fimmen BA, Thal DR, Schluesener HJ, Meyermann R (2002b) Aberrant neuronal and paracellular deposition of endostatin in brains of patients with Alzheimer’s disease. J Neurosci 22:10621–10626

    Google Scholar 

  • Deininger MH, Wybranietz WA, Graepler FT, Lauer UM, Meyermann R, Schluesener HJ (2003) Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J 17:1267–1276

    Google Scholar 

  • Ekekezie II, Thibeault DW, Rezaiekhaligh MH, Norberg M, Mabry S, Zhang X, Truog WE (2003) Endostatin and vascular endothelial cell growth factor (VEGF) in piglet lungs: effect of inhaled nitric oxide and hyperoxia. Pediatr Res 53:440–446

    Google Scholar 

  • Ergün S, Kilic N, Wurmbach JH, Ebrahimnejad A, Fernando M, Sevinc S, Kilic E, Chalajour F, Fiedler W, Lauke H, Lamszus K, Hammerer P, Weil J, Herbst H, Folkman J (2001) Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis 4:193–206

    Google Scholar 

  • Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J (2000) Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486:247–251

    Google Scholar 

  • Frisdal E, Gest V, Vieillard-Baron A, Levame M, Lepetit H, Eddahibi S, Lafuma C, Harf A, Adnot S, Dortho MP (2001) Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 18:838–845

    Google Scholar 

  • Ghafar MA, Anastasiadis AG, Olsson LE, Chichester P, Kaplan SA, Buttyan R, Levin RM (2002) Hypoxia and an angiogenic response in the partially obstructed rat bladder. Lab Invest 82:903–909

    Google Scholar 

  • Gibbs DF, Warner RL, Weiss SJ, Johnson KJ, Varani J (1999) Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol Biol 20:1136–1144

    Google Scholar 

  • Gu JW, Gadonski G, Wang J, Makey I, Adair TH (2004) Exercise increases endostatin in circulation of healthy volunteers. BMC Physiol 4:2

    Google Scholar 

  • Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkila P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307:292–304

    Google Scholar 

  • Howell K, Preston RJ, McLoughlin P (2003) Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 547:133–145

    Google Scholar 

  • John H, Preissner KT, Forssmann WG, Ständker L (1999) Novel glycosylated forms of human plasma endostatin and circulating endostatin-related fragments of collagen XV. Biochemistry 38:10217–10224

    Google Scholar 

  • Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST, Kwon YG (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 60:5410–5413

    Google Scholar 

  • Lang I, Hoffmann C, Olip H, Pabst MA, Hahn T, Dohr G, Desoye G (2001) Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif 34:143–155

    Google Scholar 

  • Miosge N, Sasaki T, Timpl R (1999) Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J 13:1743–1750

    Google Scholar 

  • Miserocchi G, Passi A, Negrini D, Del Fabbro M, De Luca G (2001) Pulmonary interstitial pressure and tissue matrix structure in acute hypoxia. Am J Physiol Lung Cell Mol Physiol 280:L881–L887

    Google Scholar 

  • Muragaki Y, Timmons S, Griffith CM, Oh SP, Fadel B, Quertermous T, Olsen BR (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci USA 92:8763–8767

    Google Scholar 

  • Nguyen M, Arkell J, Jackson CJ (2001) Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33:960–970

    Google Scholar 

  • Nyberg P, Heikkila P, Sorsa T, Luostarinen J, Heljasvaara R, Stenman UH, Pihlajaniemi T, Salo T (2003) Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J Biol Chem 278:22404–22411

    Google Scholar 

  • O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285

    Google Scholar 

  • Pascaud MA, Griscelli F, Raoul W, Marcos E, Opolon P, Raffestin B, Perricaudet M, Adnot S, Eddahibi S (2003) Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice. Am J Respir Cell Mol Biol 29:449–457

    Google Scholar 

  • Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F (2002) Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res 11:81–90

    Google Scholar 

  • Sasaki T, Fukai N, Mann K, Gohring W, Olsen BR, Timpl R (1998) Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J 17:4249–4256

    Google Scholar 

  • Seko Y, Fukuda S, Nagai R (2004) Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy. Clin Sci 106:439–442

    Google Scholar 

  • Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a “cysteine switch” mechanism for activation. Proc Natl Acad Sci USA 87:364–368

    Google Scholar 

  • Stadler W, Wilding G (2003) Angiogenesis inhibitors in genitourinary cancers. Crit Rev Oncol Hematol 46(suppl):S41–S47

    Google Scholar 

  • Strik HM, Schluesener HJ, Seid K, Meyermann R, Deininger MH (2001) Localization of endostatin in rat and human gliomas. Cancer 91:1013–1019

    Google Scholar 

  • Sumi M, Satoh H, Kagohashi K, Ishikawa H, Sekizawa K (2005) Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis. J Clin Lab Anal 19:146–149

    Google Scholar 

  • Thomas JP, Arzoomanian RZ, Alberti D, Marnocha R, Lee F, Friedl A, Tutsch K, Dresen A, Geiger P, Pluda J, Fogler W, Schiller JH, Wilding G (2003) Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol 21:223–231

    Google Scholar 

  • Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578–5582

    Google Scholar 

  • Wu P, Yonekura H, Li H, Nozaki I, Tomono Y, Naito I, Ninomiya Y, Yamamoto H (2001) Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochem Biophys Res Commun 288:1149–1154

    Google Scholar 

  • Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18:4414–4423

    Google Scholar 

  • Zaidi SH, You XM, Ciura S, Husain M, Rabinovitch M (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105:516–521

    Google Scholar 

Download references

Acknowledgements

We thank S. Wiegand, P. Hartmann and K. Michael for excellent technical assistance. The financial support of the Deutsche Forschungsgemeinschaft (SFB 547, project C1) is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renate Paddenberg.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paddenberg, R., Faulhammer, P., Goldenberg, A. et al. Hypoxia-induced increase of endostatin in murine aorta and lung. Histochem Cell Biol 125, 497–508 (2006). https://doi.org/10.1007/s00418-006-0158-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00418-006-0158-5

Keywords

Navigation